Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.

Publication Listing for the MeSH term therapeutic use. Found 398 abstracts

no pagination
Iczkowski KA, Han AC, Edelson MI, Rosenblum NG. Primary, localized vulvar B-cell lymphoma expressing CD44 variant 6 but not cadherins. A case report. J Reprod Med. 2000 Oct;45(10):853-6.
Kestin LL, Jaffray DA, Edmundson GK, Martinez AA, Wong JW, Kini VR, Chen PY, Vicini FA. Improving the dosimetric coverage of interstitial high-dose-rate breast implants. Int J Radiat Oncol Biol Phys. 2000 Jan;46(1):35-43.
Kruger WD. Vitamins and homocysteine metabolism. Vitam Horm. 2000 Jan;60:333-52.
Kruger WD, Evans AA, Wang L, Malinow MR, Duell PB, Anderson PH, Block PC, Hess DL, Graf EE, Upson B. Polymorphisms in the CBS gene associated with decreased risk of coronary artery disease and increased responsiveness to total homocysteine lowering by folic acid. Molecular genetics and metabolism. 2000 May;70(1):53-60.
Langer CJ. The role of new agents in advanced non-small-cell lung carcinoma. Current oncology reports. 2000 Jan;2(1):76-89.
Langer CJ. Advanced non-small cell lung carcinoma: the emerging role of docetaxel. Invest New Drugs. 2000 Feb;18(1):17-28.
Langer CJ, McAleer CA, Bonjo CA, Litwin S, Millenson M, Kosierowski R, Blankstein K, Alexander R, Ozols RF. Paclitaxel by 1-h infusion in combination with carboplatin in advanced non-small cell lung carcinoma (NSCLC). Eur J Cancer. 2000 Jan;36(2):183-93.
Logginidou H, Ao X, Russo I, Henske EP. Frequent estrogen and progesterone receptor immunoreactivity in renal angiomyolipomas from women with pulmonary lymphangioleiomyomatosis. Chest. 2000 Jan;117(1):25-30.
Ozols RF. Paclitaxel (Taxol)/carboplatin combination chemotherapy in the treatment of advanced ovarian cancer. Semin Oncol. 2000 Jun;27(3 Suppl 7):3-7.
Ozols RF. The role of gemcitabine in the treatment of ovarian cancer. Semin Oncol. 2000 Feb;27(1 Suppl 2):40-7.
Pendyala L, Creaven PJ, Schwartz G, Meropol NJ, Bolanowska-Higdon W, Zdanowicz J, Murphy M, Perez R. Intravenous ifosfamide/mesna is associated with depletion of plasma thiols without depletion of leukocyte glutathione. Clin Cancer Res. 2000 Apr;6(4):1314-21.
Schilder RJ, Blessing JA, Morgan M, Mangan CE, Rader JS. Evaluation of gemcitabine in patients with squamous cell carcinoma of the cervix: a Phase II study of the gynecologic oncology group. Gynecol Oncol. 2000 Feb;76(2):204-7.
Schilder RJ, Goldberg M, Millenson MM, Movsas B, Rogatko A, Rogers B, Langer CJ. Phase II trial of induction high-dose chemotherapy followed by surgical resection and radiation therapy for patients with marginally resectable non-small cell carcinoma of the lung. Lung Cancer. 2000 Jan;27(1):37-45.
Venook AP, Egorin MJ, Rosner GL, Hollis D, Mani S, Hawkins M, Byrd J, Hohl R, Budman D, Meropol NJ, Ratain MJ. Phase I and pharmacokinetic trial of gemcitabine in patients with hepatic or renal dysfunction: Cancer and Leukemia Group B 9565. J Clin Oncol. 2000 Jul;18(14):2780-7.
von Mehren M, Arlen P, Tsang KY, Rogatko A, Meropol N, Cooper HS, Davey M, McLaughlin S, Schlom J, Weiner LM. Pilot study of a dual gene recombinant avipox vaccine containing both carcinoembryonic antigen (CEA) and B7.1 transgenes in patients with recurrent CEA-expressing adenocarcinomas. Clin Cancer Res. 2000 Jun;6(6):2219-28.
Weil SC. Minimal residual disease in acute promyelocytic leukemia. Clin Lab Med. 2000 Mar;20(1):105-17, ix.
Weiner LM, Adams GP. New approaches to antibody therapy. Oncogene. 2000 Dec 11;19(53):6144-51.
Young RC. The sounds of silence. Nature. 2000 Nov 09;408(6809):141.
Zhou T, Guo JT, Nunes FA, Molnar-Kimber KL, Wilson JM, Aldrich CE, Saputelli J, Litwin S, Condreay LD, Seeger C, Mason WS. Combination therapy with lamivudine and adenovirus causes transient suppression of chronic woodchuck hepatitis virus infections. J Virol. 2000 Dec;74(24):11754-63.
Bonin SR, Pajak TF, Russell AH, Coia LR, Paris KJ, Flam MS, Sauter ER. Overexpression of p53 protein and outcome of patients treated with chemoradiation for carcinoma of the anal canal: a report of randomized trial RTOG 87-04. Radiation Therapy Oncology Group. Cancer. 1999 Mar 15;85(6):1226-33.
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

MeSH cloud from publications including the MeSH term therapeutic use

therapeutic use Human drug therapy Female Middle Age US Gov't Support-PHS Non-US Gov't Support Antineoplastic Combined Chemotherapy Protocols Male analogs & derivatives pathology therapy metabolism Treatment Outcome Lung Neoplasms Adult Neoplasms administration & dosage Aged Deoxycytidine Paclitaxel Non-Small-Cell Lung Carcinoma Drug Dose-Response Relationship blood Antineoplastic Antimetabolites Carboplatin Prognosis genetics drug effects Squamous Cell Carcinoma Retrospective Studies Homocysteine immunology Animal radiotherapy pharmacology Randomized Controlled Trials Adenocarcinoma complications Cisplatin X-Ray Computed Tomography effects Clinical Trials Phytogenic Antineoplastic Agents Pilot Projects adverse effects use Salvage Therapy pharmacokinetics epidemiology diagnosis Disease-Free Survival Neoplasm Staging Antineoplastic Agents therapeutic Ovarian Neoplasms surgery adverse prevention & control Biopsy Combined Modality Therapy Immunotherapy methods Survival Rate Glutathione mortality Granulocyte Colony-Stimulating Factor Ifosfamide Immunohistochemistry Mononuclear Leukocytes Magnetic Resonance Imaging Protective Agents Hematopoietic Stem Cell Transplantation Folic Acid Deficiency Biological Models Iridium Radioisotopes Progesterone Receptors Prospective Studies etiology Enzyme-Linked Immunosorbent Assay biosynthesis Lamivudine Analysis of Variance Neoplasm Antibodies Mesna Radiotherapy Dosage Algorithms Immunoglobulin G Bone Marrow Transplantation Kidney Failure Nutritional Status Haplotypes Combination Drug Therapy Kidney Neoplasms CD80 Antigens Multiple Primary Neoplasms US Gov't Support-Non-PHS Fluorouracil Bilirubin Residual Neoplasm Bispecific Antibodies Chronic Hepatitis B T-Lymphocytes United States Sulfhydryl Compounds Interferons Promyelocytic Leukemia-Acute Carcinoembryonic Antigen Cadherins Alkylating Antineoplastic Agents CD44 Antigens Estrogen Receptors Translocation (Genetics) Case Report Acetaldehyde Vinblastine Thoracotomy urine Cysteine Vulvar Neoplasms Quality of Life Polymorphism (Genetics) Phase III Clinical Trials Hematopoietic Stem Cell Mobilization Vitamins Vitamin B 6 Deficiency Marmota Risk Factors Antibodies Polymerase Chain Reaction Computer-Assisted Radiotherapy Planning Avipoxvirus Biological Tumor Markers Liver Diseases Virus Replication Adenoviridae Aspartate Aminotransferases Woodchuck Hepatitis B Virus Vitamin B 12 Deficiency Adjuvant Radiotherapy World Health Antibody-Dependent Cell Cytotoxicity Angiomyolipoma Bridged Compounds Neural Tube Defects Drug Administration Schedule Brachytherapy Creatinine 5-Methyltetrahydrofolate-Homocysteine S-Methyltransferase Cervix Neoplasms
Last updated on Friday, January 03, 2020